Embedded Files
Biomarker discovery in the urine of early-stage bladder cancer patients. Patented in USA, Europe, Japan, China & Singapore. Licensed to Biocheetah Pte Ltd. (PC/SW/2934/0518/ ETPL-IMCB)
Prognostic biomarkers for identification of treatment responders among CHB patients. Patent filed (IP2024-198-01)
High performing novel diagnostic urinary marker panels for early and advanced stages of Chronic Kidney Disease of uncertain etiology (CKDu) Patent filed (10202501285T)
A high performing novel protein marker for predicting the immunological phenotype of triple negative breast cancer (TNBC) Patent filed (10202500800Y)Â
Institute of Molecular and Cell Biology61 Biopolis Drive, #7-12/13, Proteos, Singapore 138673
Page updated
Google Sites
Report abuse